Novel kidney dialysis devices will be available to patients faster, under a new plan launched by the U.S. Food and Drug Administration (FDA) designed to respond to medical innovation. The program, “Innovation Pathway,” aims to reduce the time and cost of bringing safe and effective breakthrough technologies to patients, FDA says in a press release. [...]